Skip to content
Recall Observatory FDA recall evidence

Device product

HemosIL ReadiPlasTin (20 mL), Part number 0020301400. An in vitro diagnostic thromboplastin reagent.

Z-0276-2022

October 13, 2021

Class II

Product summary

Firm
Instrumentation Laboratory
Event
Event 88930
Status
Ongoing
Classification
Class II
Quantity
5828 kits (310 US)
Official record key
device-enforcement:Z-0276-2022

Official wording

Reason: The firm has received customer reports of performance issues with the affected lot, including increased imprecision, out of range quality controls, and prolonged sample results. If quality controls are not performed or do not pass for each vial of reagent, there is a potential risk of reporting an erroneous result.

Code information: Lot N0705526 UDI: 08426950632887 ***Updated 3/3/22*** Firm has expanded recall to include the following lot: N0806224

Distribution pattern: Worldwide distribution - US Nationwide distribution in the states of AZ, CA, IA, IL, KS, ME, MI, NC, NY, OK, SC, and VA. The countries of Canada, Chile, China, Costa Rica, Italy, Japan, and South Korea. ***Updated 3/3/22*** Expansion includes states of IN, MN, and NC.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    The firm has received customer reports of performance issues with the affected lot, including increased imprecision, out of range quality controls, and prolonged sample results. If quality controls are not performed or do not pass for each vial of reagent, there is a potential risk of reporting an erroneous result.